对小儿霍奇金淋巴瘤幸存者 21 年随访期间的后期影响进行评估:土耳其儿科癌症中心的经验,作为发展中国家的典范。

IF 0.9 4区 医学 Q4 ONCOLOGY Indian journal of cancer Pub Date : 2024-04-01 Epub Date: 2024-01-09 DOI:10.4103/ijc.IJC_912_20
Nurdan Tacyildiz, Hatice M Cakmak, Emel Unal, Handan Dincaslan, Gulsah Tanyıldız, Sonay I Özdemir, Ömer Kartal, Yasin Yılmaz, Gulsan Yavuz, Işınsu Kuzu
{"title":"对小儿霍奇金淋巴瘤幸存者 21 年随访期间的后期影响进行评估:土耳其儿科癌症中心的经验,作为发展中国家的典范。","authors":"Nurdan Tacyildiz, Hatice M Cakmak, Emel Unal, Handan Dincaslan, Gulsah Tanyıldız, Sonay I Özdemir, Ömer Kartal, Yasin Yılmaz, Gulsan Yavuz, Işınsu Kuzu","doi":"10.4103/ijc.IJC_912_20","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Long-term survivors of Hodgkin lymphoma (HL) are at risk of developing a range of late effects, with a second malignant neoplasm and cardiovascular diseases being the leading causes of death in these patients. The present study aims to evaluate the late side effects in children with HL.</p><p><strong>Materials and methods: </strong>Out of 53 HL patients, we assessed the long-term effects of childhood HL survivors (HLSs; n = 50) diagnosed between 1998 and 2019. Patient data related to chronic health conditions, and sociodemographic characteristics were compared with their siblings ( n = 56).</p><p><strong>Results: </strong>The cumulative overall survival (OS) at 1, 5, and 10 years from diagnosis was 98.1 ± 1.9%, 93.3 ± 3.8%, and 93.3 ± 3.8%, respectively. Groups of HLSs and their siblings were matched according to age and gender. Compared with siblings, survivors had will be changed as 'a higher frequency of nephrotoxicity ( P = 0.02)', cardiotoxicity ( P = 0.12), thyroid dysfunction ( P = 0.001), health care service usage ( P < 0.01), limitation of physical function ( P = 0.01), and pulmonary disease ( P = 0.01). The control group of siblings had a higher incidence of marital status ( P < 0.01), parenthood ( P = 0.01), and smoking habit ( P = 0.03). Thyroid dysfunction was associated with neck radiotherapy ( P < 0.01). No secondary neoplasm was detected. In relapsed, refractory setting ( n = 10), autologous transplantation ( n = 9) is performed after a complete remission. Brentuximab vedotin with or without bendamustine and rituximab is also used in selected patients.</p><p><strong>Conclusions: </strong>Increased number of chronic health conditions and social problems point to the significance of long-term follow-up of HLSs. We are currently preparing a survivorship guideline appropriate for Turkey's conditions.</p><p><strong>Implications for cancer survivors: </strong>Renal, heart, pulmonary impairment, thyroid dysfunction, limitation in physical functioning, and deterioration in social status (marriage, having children, education).</p>","PeriodicalId":13505,"journal":{"name":"Indian journal of cancer","volume":" ","pages":"282-289"},"PeriodicalIF":0.9000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluation of late effects during a 21-year follow-up of pediatric Hodgkin lymphoma survivors: Experience of a pediatric cancer center in Turkey, as a developing country model.\",\"authors\":\"Nurdan Tacyildiz, Hatice M Cakmak, Emel Unal, Handan Dincaslan, Gulsah Tanyıldız, Sonay I Özdemir, Ömer Kartal, Yasin Yılmaz, Gulsan Yavuz, Işınsu Kuzu\",\"doi\":\"10.4103/ijc.IJC_912_20\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Long-term survivors of Hodgkin lymphoma (HL) are at risk of developing a range of late effects, with a second malignant neoplasm and cardiovascular diseases being the leading causes of death in these patients. The present study aims to evaluate the late side effects in children with HL.</p><p><strong>Materials and methods: </strong>Out of 53 HL patients, we assessed the long-term effects of childhood HL survivors (HLSs; n = 50) diagnosed between 1998 and 2019. Patient data related to chronic health conditions, and sociodemographic characteristics were compared with their siblings ( n = 56).</p><p><strong>Results: </strong>The cumulative overall survival (OS) at 1, 5, and 10 years from diagnosis was 98.1 ± 1.9%, 93.3 ± 3.8%, and 93.3 ± 3.8%, respectively. Groups of HLSs and their siblings were matched according to age and gender. Compared with siblings, survivors had will be changed as 'a higher frequency of nephrotoxicity ( P = 0.02)', cardiotoxicity ( P = 0.12), thyroid dysfunction ( P = 0.001), health care service usage ( P < 0.01), limitation of physical function ( P = 0.01), and pulmonary disease ( P = 0.01). The control group of siblings had a higher incidence of marital status ( P < 0.01), parenthood ( P = 0.01), and smoking habit ( P = 0.03). Thyroid dysfunction was associated with neck radiotherapy ( P < 0.01). No secondary neoplasm was detected. In relapsed, refractory setting ( n = 10), autologous transplantation ( n = 9) is performed after a complete remission. Brentuximab vedotin with or without bendamustine and rituximab is also used in selected patients.</p><p><strong>Conclusions: </strong>Increased number of chronic health conditions and social problems point to the significance of long-term follow-up of HLSs. We are currently preparing a survivorship guideline appropriate for Turkey's conditions.</p><p><strong>Implications for cancer survivors: </strong>Renal, heart, pulmonary impairment, thyroid dysfunction, limitation in physical functioning, and deterioration in social status (marriage, having children, education).</p>\",\"PeriodicalId\":13505,\"journal\":{\"name\":\"Indian journal of cancer\",\"volume\":\" \",\"pages\":\"282-289\"},\"PeriodicalIF\":0.9000,\"publicationDate\":\"2024-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Indian journal of cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.4103/ijc.IJC_912_20\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/9 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian journal of cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4103/ijc.IJC_912_20","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/9 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:霍奇金淋巴瘤(HL)的长期存活者有可能出现一系列晚期副作用,第二次恶性肿瘤和心血管疾病是这些患者的主要死因。本研究旨在评估 HL 儿童的晚期副作用:在 53 名 HL 患者中,我们评估了 1998 年至 2019 年期间确诊的儿童 HL 幸存者(HLS;n = 50)的长期影响。将患者的慢性健康状况相关数据和社会人口学特征与他们的兄弟姐妹(n = 56)进行了比较:结果:确诊后1年、5年和10年的累积总生存率(OS)分别为(98.1 ± 1.9%)、(93.3 ± 3.8%)和(93.3 ± 3.8%)。根据年龄和性别对高危人群及其兄弟姐妹进行了配对。与同胞相比,幸存者的肾毒性(P = 0.02)、心脏毒性(P = 0.12)、甲状腺功能障碍(P = 0.001)、医疗服务使用率(P < 0.01)、身体功能限制(P = 0.01)和肺部疾病(P = 0.01)的发生率更高。对照组兄弟姐妹的婚姻状况(P < 0.01)、父母身份(P = 0.01)和吸烟习惯(P = 0.03)发生率较高。甲状腺功能障碍与颈部放疗有关(P < 0.01)。未发现继发性肿瘤。在复发、难治的情况下(n = 10),完全缓解后进行自体移植(n = 9)。布伦妥昔单抗维多汀联合或不联合苯达莫司汀和利妥昔单抗也用于部分患者:结论:慢性健康状况和社会问题的增加表明,对高危人群进行长期随访具有重要意义。目前,我们正在制定适合土耳其国情的幸存者指南:肾、心、肺功能损害,甲状腺功能障碍,身体机能受限,社会地位恶化(婚姻、生育、教育)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Evaluation of late effects during a 21-year follow-up of pediatric Hodgkin lymphoma survivors: Experience of a pediatric cancer center in Turkey, as a developing country model.

Background: Long-term survivors of Hodgkin lymphoma (HL) are at risk of developing a range of late effects, with a second malignant neoplasm and cardiovascular diseases being the leading causes of death in these patients. The present study aims to evaluate the late side effects in children with HL.

Materials and methods: Out of 53 HL patients, we assessed the long-term effects of childhood HL survivors (HLSs; n = 50) diagnosed between 1998 and 2019. Patient data related to chronic health conditions, and sociodemographic characteristics were compared with their siblings ( n = 56).

Results: The cumulative overall survival (OS) at 1, 5, and 10 years from diagnosis was 98.1 ± 1.9%, 93.3 ± 3.8%, and 93.3 ± 3.8%, respectively. Groups of HLSs and their siblings were matched according to age and gender. Compared with siblings, survivors had will be changed as 'a higher frequency of nephrotoxicity ( P = 0.02)', cardiotoxicity ( P = 0.12), thyroid dysfunction ( P = 0.001), health care service usage ( P < 0.01), limitation of physical function ( P = 0.01), and pulmonary disease ( P = 0.01). The control group of siblings had a higher incidence of marital status ( P < 0.01), parenthood ( P = 0.01), and smoking habit ( P = 0.03). Thyroid dysfunction was associated with neck radiotherapy ( P < 0.01). No secondary neoplasm was detected. In relapsed, refractory setting ( n = 10), autologous transplantation ( n = 9) is performed after a complete remission. Brentuximab vedotin with or without bendamustine and rituximab is also used in selected patients.

Conclusions: Increased number of chronic health conditions and social problems point to the significance of long-term follow-up of HLSs. We are currently preparing a survivorship guideline appropriate for Turkey's conditions.

Implications for cancer survivors: Renal, heart, pulmonary impairment, thyroid dysfunction, limitation in physical functioning, and deterioration in social status (marriage, having children, education).

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Indian journal of cancer
Indian journal of cancer Medicine-Oncology
CiteScore
1.40
自引率
0.00%
发文量
67
审稿时长
>12 weeks
期刊介绍: Indian Journal of Cancer (ISSN 0019-509X), the show window of the progress of ontological sciences in India, was established in 1963. Indian Journal of Cancer is the first and only periodical serving the needs of all the specialties of oncology in India.
期刊最新文献
Carcinoma colon masquerading as bleeding per vagina. Gene of the month: C-KIT. Assessment of quality of life in head and neck cancer patients visiting the Palliative Care outpatient department in a tertiary care oncology centre in India. Introduction of HPV vaccine in universal immunization programme of India: A step in the right direction for the elimination of cervical cancer. Role of adaptive radiotherapy during concomitant chemoradiotherapy for limited-stage small-cell lung cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1